Connor, Clark & Lunn Investment Management (CC&L)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $559K | Sell |
|
|||||
|
2024
Q2 | $1.79M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $19.1M | Buy |
|
|||||
|
2021
Q4 | $26.3M | Sell |
|
|||||
|
2021
Q3 | $38.3M | Buy |
|
|||||
|
2021
Q2 | $14.3M | Buy |
|
|||||
|
2021
Q1 | $6.45M | Sell |
|
|||||
|
2020
Q4 | $6.92M | Sell |
|
|||||
|
2020
Q3 | $7.16M | Buy |
|
|||||
|
2020
Q2 | $3.71M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $292K | Buy |
|
|||||
|
2018
Q2 | $55K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $669K | Buy |
|
|||||
|
2014
Q4 | $245K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.64M | Buy |
|